Bank of Montreal’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.7M | Buy |
230,072
+10,717
| +5% | +$836K | 0.01% | 886 |
|
|
2025
Q4 | $17.3M | Buy |
219,355
+25,108
| +13% | +$2.17M | 0.01% | 903 |
|
|
2025
Q3 | $17.8M | Sell |
194,247
-17,981
| -8% | -$1.47M | 0.01% | 824 |
|
|
2025
Q2 | $13.8M | Sell |
212,228
-3,493
| -2% | -$227K | 0.01% | 858 |
|
|
2025
Q1 | $14.4M | Sell |
215,721
-14,432
| -6% | -$862K | 0.01% | 809 |
|
|
2024
Q4 | $12.7M | Buy |
230,153
+8,257
| +4% | +$474K | 0.01% | 907 |
|
|
2024
Q3 | $13M | Buy |
+221,896
| New | +$13.5M | 0.01% | 935 |
|
|
2024
Q1 | – | Sell |
-8,477
| Closed | -$469K | – | 3863 |
|
|
2023
Q4 | $469K | Buy |
+8,477
| New | +$467K | ﹤0.01% | 2546 |
|
|
2021
Q2 | – | Sell |
-2,724
| Closed | -$87K | – | 3690 |
|
|
2021
Q1 | $87K | Sell |
2,724
-3,120
| -53% | -$97.7K | ﹤0.01% | 3453 |
|
|
2020
Q4 | $185K | Buy |
5,844
+1,362
| +30% | +$39K | ﹤0.01% | 3260 |
|
|
2020
Q3 | $131K | Sell |
4,482
-1,009
| -18% | -$30K | ﹤0.01% | 2940 |
|
|
2020
Q2 | $145K | Sell |
5,491
-13,831
| -72% | -$496K | ﹤0.01% | 2893 |
|
|
2020
Q1 | $748K | Buy |
19,322
+219
| +1% | +$11.6K | ﹤0.01% | 1813 |
|
|
2019
Q4 | $1.18M | Buy |
19,103
+15,653
| +454% | +$1.04M | ﹤0.01% | 2169 |
|
|
2019
Q3 | $251K | Buy |
3,450
+503
| +17% | +$37.6K | ﹤0.01% | 2772 |
|
|
2019
Q2 | $242K | Sell |
2,947
-1,977
| -40% | -$141K | ﹤0.01% | 2820 |
|
|
2019
Q1 | $349K | Sell |
4,924
-53
| -1% | -$3.12K | ﹤0.01% | 2454 |
|
|
2018
Q4 | $225K | Sell |
4,977
-4,058
| -45% | -$213K | ﹤0.01% | 2517 |
|
|
2018
Q3 | $511K | Buy |
9,035
+129
| +1% | +$7.89K | ﹤0.01% | 2324 |
|
|
2018
Q2 | $595K | Buy |
8,906
+2
| +0% | +$125 | ﹤0.01% | 2248 |
|
|
2018
Q1 | $519K | Buy |
8,904
+6,496
| +270% | +$412K | ﹤0.01% | 2207 |
|
|
2017
Q4 | $156K | Buy |
2,408
+2,100
| +682% | +$131K | ﹤0.01% | 2794 |
|
|
2017
Q3 | $16K | Hold |
308
| – | – | ﹤0.01% | 3577 |
|
|
2017
Q2 | $14K | Buy |
308
+242
| +367% | +$11.7K | ﹤0.01% | 3630 |
|
|
2017
Q1 | $3K | Sell |
66
-2,372
| -97% | -$133K | ﹤0.01% | 3763 |
|
|
2016
Q4 | $144K | Buy |
2,438
+10
| +0.4% | +$611 | ﹤0.01% | 2657 |
|
|
2016
Q3 | $161K | Sell |
2,428
-749
| -24% | -$46.8K | ﹤0.01% | 2537 |
|
|
2016
Q2 | $177K | Sell |
3,177
-774
| -20% | -$37.6K | ﹤0.01% | 2527 |
|
|
2016
Q1 | $133K | Sell |
3,951
-2,805
| -42% | -$95.1K | ﹤0.01% | 2671 |
|
|
2015
Q4 | $305K | Buy |
6,756
+4,642
| +220% | +$200K | ﹤0.01% | 2191 |
|
|
2015
Q3 | $84K | Hold |
2,114
| – | – | ﹤0.01% | 2709 |
|
|
2015
Q2 | $131K | Buy |
2,114
+830
| +65% | +$49.4K | ﹤0.01% | 2604 |
|
|
2015
Q1 | $80K | Buy |
+1,284
| New | +$78.1K | ﹤0.01% | 2728 |
|
|
2014
Q1 | – | Sell |
-6,000
| Closed | -$120K | – | 3991 |
|
|
2013
Q4 | $120K | Buy |
+6,000
| New | +$77.8K | ﹤0.01% | 2456 |
|
Other funds holding ANIP
VCM
SCM
TCM
GAM
DTC
Bank of Montreal's ANIP Position: Q1 2026 in Review
Bank of Montreal increased its ANI Pharmaceuticals (ANIP) stake by 4.9% in Q1 2026, buying an estimated $836K and bringing the position to 230,072 shares worth $17.7M. The position accounts for 0.01% of the portfolio, ranked #886.
Bank of Montreal first reported a position in ANIP in Q4 2013 and has held it in 34 quarters since. The position peaked at $17.8M in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.
- Bank of Montreal held 230,072 shares of ANI Pharmaceuticals worth $17.7M as of Q1 2026.
- Bank of Montreal bought 10,717 ANI Pharmaceuticals shares in Q1 2026, an estimated $836K.
- ANI Pharmaceuticals made up 0.01% of Bank of Montreal's portfolio in Q1 2026, its #886 holding.
- Bank of Montreal first reported a position in ANI Pharmaceuticals in Q4 2013 and has held it in 34 quarters since.
- Bank of Montreal's ANI Pharmaceuticals position peaked at $17.8M in Q3 2025.
- 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.